GlassScriptPhysician profile
Robert J Montemurro
NPI 1619919651
$1,327.56
in general payments reported to CMS, 2019-2025
24 companies · $36.52 in 2025
The $36.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $147 · 2021: $166 · 2022: $405 · 2023: $212 · 2024: $90.58 · 2025: $36.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $171.20 | 2021-2025 | |
| Myovant Sciences INC. | $164.18 | 2021-2022 | |
| Exeltis, USA INC. | $124.50 | 2019-2024 | Slynd |
| Abbvie INC. | $121.96 | 2019-2023 | |
| Agile Therapeutics, INC. | $88.68 | 2021-2023 | Twirla |
| Pfizer INC. | $63.56 | 2019-2022 | |
| Evofem Biosciences, INC. | $61.45 | 2021-2022 | |
| Ethicon US, LLC | $60.52 | 2020-2023 | Stratafix, Dermabond |
| Therapeuticsmd, INC. | $55.68 | 2019-2022 | |
| Davol INC. | $53.58 | 2020 | |
| Duchesnay USA Incorporated | $51.81 | 2019 | |
| Avanos Medical | $41.86 | 2019-2021 | |
| Organon LLC | $32.73 | 2024 | |
| Millicent US INC | $31.17 | 2019-2025 | Femlyv |
| Allergan, INC. | $29.38 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $27.34 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $26.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.18 | 2020 | |
| Laborie Medical Technologies Corp. | $19.86 | 2024 | Traxi Panniculus Retractor |
| Astellas Pharma US INC | $18.32 | 2024 | Veozah |
| Mallinckrodt Enterprises LLC | $14.98 | 2019 | |
| Mission Pharmacal Company | $14.85 | 2019 | |
| Lupin INC. | $14.78 | 2020 | |
| Mycovia Pharmaceuticals, INC. | $14.55 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Montemurro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.